Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Skye Bioscience, Inc. (SKYE) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Skye Bioscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1516551.
Total stock buying since 2015: $125,012,042,769.
Total stock sales since 2015: $6,804,414.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 462,810 | $1,601,094 | 0 | $0 |
| 2024 | 5,206,074 | $12,026,030 | 765,105 | $4,661,060 | 0 | $0 |
| 2023 | 881,000 | $16,739 | 0 | $0 | 0 | $0 |
| 2020 | 1,500,000 | $125,000,000,000 | 3,000,000 | $300,000 | 0 | $0 |
| 2018 | 15,000,000 | $0 | 0 | $0 | 0 | $0 |
| 2015 | 0 | $0 | 50,630 | $242,260 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 462,810 | $1,601,094 | 0 | $0 |
| 2024-11 | 0 | $0 | 232,431 | $1,160,356 | 0 | $0 |
| 2024-09 | 0 | $0 | 532,674 | $3,500,704 | 0 | $0 |
| 2024-01 | 5,206,074 | $12,026,030 | 0 | $0 | 0 | $0 |
| 2023-08 | 881,000 | $16,739 | 0 | $0 | 0 | $0 |
| 2020-08 | 1,500,000 | $125,000,000,000 | 3,000,000 | $300,000 | 0 | $0 |
| 2018-02 | 15,000,000 | $0 | 0 | $0 | 0 | $0 |
| 2015-04 | 0 | $0 | 50,630 | $242,260 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | Schwab Andrew J. | Sale | 170,449 | 3.42 | 582,935 |
| 2025-08-22 | Rocklage Scott M | Sale | 170,449 | 3.42 | 582,935 |
| 2025-08-21 | Schwab Andrew J. | Sale | 60,956 | 3.57 | 217,612 |
| 2025-08-21 | Rocklage Scott M | Sale | 60,956 | 3.57 | 217,612 |
| 2024-11-18 | Diep Tuan Tu (Chief Development Officer) | Sale | 19,489 | 4.99 | 97,250 |
| 2024-11-18 | Arsenault Kaitlyn (Chief Financial Officer) | Sale | 43,206 | 4.99 | 215,597 |
| 2024-11-18 | Grayson Paul A. (Director) | Sale | 86,244 | 4.99 | 430,357 |
| 2024-11-18 | Dhillon Punit (Chief Executive Officer) | Sale | 82,546 | 4.99 | 411,904 |
| 2024-11-15 | Diep Tuan Tu (Chief Development Officer) | Sale | 85 | 5.55 | 471 |
| 2024-11-15 | Arsenault Kaitlyn (Chief Financial Officer) | Sale | 190 | 5.55 | 1,054 |
| 2024-11-15 | Grayson Paul A. (Director) | Sale | 307 | 5.55 | 1,703 |
| 2024-11-15 | Dhillon Punit (Chief Executive Officer) | Sale | 364 | 5.55 | 2,020 |
| 2024-09-13 | Schwab Andrew J. | Sale | 13,837 | 6.06 | 83,852 |
| 2024-09-13 | Rocklage Scott M | Sale | 13,837 | 6.06 | 83,852 |
| 2024-09-11 | Schwab Andrew J. | Sale | 252,500 | 6.60 | 1,666,500 |
| 2024-09-11 | Rocklage Scott M | Sale | 252,500 | 6.60 | 1,666,500 |
| 2024-01-31 | Rocklage Scott M (10% Owner) | Buy | 5,206,074 | 2.31 | 12,026,030 |
| 2023-08-29 | Dhillon Punit (Chief Executive Officer) | Buy | 881,000 | .02 | 16,739 |
| 2020-08-01 | Emerald Health Sciences Inc. | Sale | 3,000,000 | .10 | 300,000 |
| 2020-08-01 | Dhillon Punit (CEO) | Buy | 1,000,000 | 100,000.00 | 100,000,000,000 |
| 2020-08-01 | Heppell James L | Buy | 500,000 | 50,000.00 | 25,000,000,000 |
| 2018-02-16 | Emerald Health Sciences Inc. (10% Owner) | Buy | 15,000,000 | .00 | 0 |
| 2015-04-10 | Ladin Brian D (10% Owner) | Sale | 11,830 | 4.93 | 58,310 |
| 2015-04-08 | Ladin Brian D (10% Owner) | Sale | 38,800 | 4.74 | 183,950 |
Insider trading activities including stock purchases, stock sales, and option exercises of SKYE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Skye Bioscience, Inc. (symbol SKYE, CIK number 1516551) see the Securities and Exchange Commission (SEC) website.